Original Research Article
Behavioral Differences between White Matter Lacunar Dementia and Alzheimer’s Disease: A Comparison on the Neuropsychiatric InventoryAharon-Peretz J. · Kliot D. · Tomer R.
Cognitive Neurology Unit, Rambam Medical Center, Haifa, Israel
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background and Purpose: Behavioral abnormalities account for much of the morbidity of vascular dementia (VaD) and Alzheimer’s disease (AD). The goals of the study were to compare the behavioral changes in patients with VaD associated with ischemic white matter subcortical changes and lacunar infarctions (VaD-WSI) to those in patients with AD. Methods: Thirty outpatients with VaD and multiple lacunar infarctions in the periventricular white matter and 30 AD patients, matched for age and severity of dementia, were enrolled in this prospective study. The behavioral abnormalities of these patients were assessed by interviewing their caregivers with the Neuropsychiatric Inventory. Results: A similar spectrum of noncognitive behavioral changes was found in AD and WSI patients. In VaD-WSI, the severity of delusions, hallucinations, aggression, irritability, aberrant motor behavior, nighttime behavior and appetite changes was correlated with cognitive decline, whereas depression, apathy, anxiety and euphoria were unrelated to the severity of dementia. In AD, none of the behavioral changes correlated with the severity of dementia. Conclusion: Behavioral changes are frequent in VaD-WSI and are present regardless of the severity of the cognitive decline. It is therefore important to assess behavioral as well as cognitive changes at early stages of the illness, to ensure appropriate treatment.
© 2000 S. Karger AG, Basel
- Rocca WA, Hofman A, Brayne C, Bretler MM, Clarke M, Coperland JR, Dartigues JF, Engedal K, Hangell O, Heeren TJ, et al: The prevalence of vascular dementia in Europe: Facts and fragments from 1980–1990 studies. Ann Neurol 1991;30:817–824.
Roman GC: Lacunar dementia; in Hutton JT, Kenny A (eds): Senile Dementia of the Alzheimer’s Type. New York, Liss, 1985, pp 131–151.
- Corbett AJ, Bennett H, Kos S: Cognitive dysfunction following subcortical infarction. Arch Neurol 1994;51:999–1007.
- Wolfe N, Linn R, Babikian VL, Albert ML: Frontal system impairment following multiple lacunar infarcts. Arch Neurol 1990;47:129–132.
Cummings JL: Subcortical dementia. New York, Oxford University Press, 1990.
- Kertez A, Clydesdale S: Neuropsychological deficits in vascular dementia vs Alzheimer’s disease. Frontal lobe deficits prominent in vascular dementia. Arch Neurol 1994;51:1226–1231.
- Padovani A, Di Piero V, Bragoni M, Iacoboni M, Gualdi GF, Lenzi GL: Patterns of neuropsychological impairment in mild dementia: A comparison between Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 1995;92:433–442.
- Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL: A comparison of psychiatric symptoms in vascular dementia and Alzheimer’s disease. Am J Psychiatry 1993;150:1806–1812.
- Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbry WR: Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997;277:813–817.
Mirra SS, Gearing M: Brain infarction and the clinical expression of Alzheimer disease. JAMA 1997;278:113.
- McKhan G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944.
- Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgozogo JM, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Benett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bougosslavsky J, Hartman A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
- Cummings JL, Mega MS, Gray K, et al: The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
- Folstein M, Folstein S, McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
- Cummings JL: Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873–880.
Pincus JH: Agression, criminality, and the frontal lobes; in Miller BL, Cummings JL (eds): The Human Frontal Lobes. Guilford Press, 1999, pp 547–556.
- Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C: Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and positron emission tomographic findings. Arch Neurol 1995;52:773–780.
- Sabri O, Ringelstein EB, Hellwig D, Schneider R, Schreckenberger M, Kaiser HJ, Mull M, Buell U: Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with the severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999;30:556–566.
- Mielke R, Heiss WD: Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia. J Neural Transm Suppl 1998;53:237–250.
Jagust WJ, Friedland R, Budinger T, Koss E, Ober B: Longitudinal studies of regional cerebral metabolism in Alzheimer’s disease. Neurology 1988;38:909–912.
- Mega MS, Cummings JL, Fiorello T, Gornbein J: The spectrum of behavioral changes in Alzheimer’s disease. Neurology 1996;46:130–135.
Cummings JL: Depression in vascular dementia. Hillside J Clin Psychiatry 1998;10:2009–2231.
Aharon-Peretz J, Kliot D, Sprecher E, Peretz A: SPECT findings in dementia. Neurology 1999;52(suppl 2):A366.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.